Priya Rao, M.D.

Peer-Reviewed Articles

1. Ruiz-Cordero, R, Wang, Q, Kumar, G, Akgul, M, Creighton, CJ, Rao, P, Tamboli, P, Zheng, L, Zhao, J, Murugan, P, Shen, SS, Brimo, F, Ezhilarasan, R, Sulman, EP, Wani, K, Lazar, A, Kim, T, Chen, K, Bhat, KP, Kannan, KS, Wang, J, Karam, JA, Sircar, K. Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples. European Urology Oncology 8(6):1629-1638, 2025. e-Pub 2025. PMID: 41193273.
2. Soeung, M, Yan, X, Zanca, C, Qian, J, Karki, M, Duan, F, Khan, H, Zhang, L, Peng, D, Williams, M, He, R, Chen, Z, Perelli, L, Chen, J, Tidwell, R, Chauhan, PK, Le, C, Lam, TA, Bhattacharya, N, Shah, R, Ho, IL, Gay, J, Carrillo, CC, Feng, N, Le, K, Gao, G, Perry, TL, Mseeh, F, Jiang, Y, Xu, Q, Zacharias, NM, Sheth, RA, Bathala, TK, Rao, P, Daw Bitar, N, Tripathi, DN, Walker, CL, Mohammad, MM, Zhang, J, Han, G, Chu, Y, Wang, R, Dang, M, Dai, E, Peng, F, Liu, Y, Jadhav, A, Lang, W, Arrechedera, C, Clemente, LC, Parra Cuentas, ER, Lu, H, Haymaker, CL, Wistuba, II, Futreal, A, Viale, A, Soth, MJ, Jones, PH, Marszalek, JR, Heffernan, TP, Draetta, G, Tannir, NM, Gao, J, Wang, L, Genovese, G, Msaouel, P. Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma. Nature communications 16(1), 2025. e-Pub 2025. PMID: 41290625.
3. Millward, NZ, Ozambela, M, Karki, M, He, R, Chauhan, PK, Pesquera, P, Hernandez Gonzalez, AE, Ochoa, O, Pieretti, AC, Chen, H, de la Cerda, C, Yu, Z, Grover, A, Hicks-Peňa, S, Fowlkes, NW, Wang, L, Maity, T, Rao, P, Genovese, G, Tannir, NM, Karam, JA, Msaouel, P. Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase–Deficient Renal Cell Carcinoma. Molecular cancer therapeutics 24(11):1722-1732, 2025. e-Pub 2025. PMID: 40601845.
4. Jackson, J, Johns, AC, Campos Clemente, L, Manuel, C, Qiao, W, Lu, W, Khan, KB, Solis Soto, LM, Chahoud, J, Rao, P, Campbell, M, Pettaway, CA, Millward, NZ. Tissue Factor Expression in Penile Squamous Cell Carcinoma. Cancers 17(21), 2025. e-Pub 2025. PMID: 41228204.
5. Wu, DX, Akgul, M, Williamson, SR, Pacheco, R, Acosta, A, Al-Obaidy, KI, Amin, MB, Berney, D, Brimo, F, Cheng, L, Colecchia, M, Comperat, EM, Cornejo, KM, Dhillon, J, Downes, MR, Epstein, J, Hirsch, M, Jimenez, R, Kaushal, S, Lobo, A, Lopez-Beltran, A, Mehra, R, Mohanty, SK, Paner, GP, Rao, P, Reuter, V, Shah, RB, Shen, S, Smith, SC, Tretiakova, M, Trpkov, K, Wobker, SE, Tamboli, P, Zynger, DL, Sangoi, AR. Interobserver reproducibility of hilar soft tissue invasion in testicular germ cell tumours among genitourinary pathologists. Histopathology 87(5):677-686, 2025. e-Pub 2025. PMID: 40611804.
6. Moussa MJ, Khandelwal J, Wilson NR, Malikayil KL, Surasi DS, Bathala TK, Lin Y, Rao P, Tamboli P, Sircar K, Ajufo H, Elsayes KM, Shah A, Johns AC, Goswami S, Hasanov E, Jonasch E, Msaouel P, Campbell MT, Alhalabi O, Tannir NM. Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma. J Immunother Cancer 13(2), 2025. e-Pub 2025. PMID: 39939142.
7. Kontoyiannis, PD, Kuykendal, A, Tang, C, Cheng, JP, Chan, B, Thomas, SS, Rao, P, Lim, B, Msaouel, P. Case Report. Frontiers in Oncology 15, 2025. e-Pub 2025. PMID: 40951353.
8. Diab M, Rao P, Ezzeldin R, Mohseni A, Rupe ES, Shi AA, Klekers AR, Prasad SR. Update on Tumor Genetics and Molecular Biology of Selected Renal Cell Carcinomas: Implications on Diagnosis and Management. Semin Roentgenol 60(1):88-102, 2025. e-Pub 2025. PMID: 39914912.
9. Msaouel P, Yu K, Yuan Y, Chen J, Yan X, Karki M, Duan F, Sheth RA, Rao P, Sircar K, Shah AY, Zurita AJ, Genovese G, Li M, Yeh CC, Dang M, Han G, Chu Y, Hallin M, Olson P, Yang R, Slavin D, Der-Torossian H, Chin CD, Tannir NM, Wang L, Gao J. Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial. Nat Commun 16(1):578, 2025. e-Pub 2025. PMID: 39794332.
10. Gubbiotti MA, McCutcheon IE, Rao P, Genovese G, Wang L, Tarasov A, Putintsev V, Berlinski A, Stupichev D, Kriukov K, Davitavyan S, Salem B, Sarachakov A, Lebedev D, Hensley M, Bagaev A, Paradiso F, Kushnarev V, Khegai G, Tannir NM, Msaouel P. A novel case of glial transdifferentiation in renal medullary carcinoma brain metastasis. Acta Neuropathol Commun 13(1):12, 2025. e-Pub 2025. PMID: 39833894.
11. Grimm SL, Karki M, Blum KA, Bertocchio JP, He R, Tripathi DN, Zacharias NM, Lebenthal JM, Sheth RA, Rao P, Genovese G, Lu Z, Bast RC, Ingram DR, Lazcano R, Wani KM, Wang WL, Lazar AJ, Tannir NM, Walker CL, Coarfa C, Msaouel P. CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation. Clin Cancer Res 31(6):1057-1068, 2025. e-Pub 2025. PMID: 39836407.
12. Mohanty SK, Lobo A, Jha S, Sangoi AR, Akgul M, Trpkov K, Hes O, Mehra R, Hirsch MS, Moch H, Smith SC, Shah RB, Cheng L, Amin MB, Epstein JI, Parwani AV, Delahunt B, Desai S, Przybycin CG, Manini C, Luthringer DJ, Sirohi D, Jain D, Midha D, Jain E, Maclean F, Giannico GA, Paner GP, Martignoni G, Al-Ahmadie HA, McKenney J, Srigley JR, Lopez JI, Kunju LP, Browning L, Aron M, Picken MM, Tretiakova M, Zhou M, Sable M, Kuroda N, Pattnaik N, Gupta NS, Rao P, Fine SW, Mishra P, Adhya AK, Kulkarni BN, Dixit M, Baisakh MR, Arora S, Sancheti S, Menon S, Wobker SE, Tickoo SK, Kaushal S, Soni S, Kandukuri S, Sharma S, Mitra S, Reuter VE, Malik V, Rao V, Chen YB, Williamson SR. Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists. Virchows Arch 485(5):829-840, 2024. e-Pub 2024. PMID: 39287823.
13. Goswami S, Gao J, Basu S, Shapiro DD, Karam JA, Tidwell RS, Ahrar K, Campbell MT, Shen Y, Trevino AE, Mayer AT, Espejo AB, Seua C, Macaluso MD, Chen Y, Liu W, He Z, Yadav SS, Wang Y, Rao P, Zhao L, Zhang J, Jindal S, Futreal A, Wang L, Tannir NM, Sharma P. Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinoma. Res Sq, 2024. e-Pub 2024. PMID: 39606482.
14. Campbell MT, Shah AY, Msaouel P, Tannir NM, Siefker-Radtke AO, Kamat AM, Navai N, Dinney CPN, Rao P, Guo CC, Sheth RA, Venkatesan AM, Tidwell RS, Yadav SS, Gu A, Chen H, Macaluso M, Duan F, Basu S, Jindal S, Sharma P. A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer. Cancer Res Commun 4(9):2444-2453, 2024. e-Pub 2024. PMID: 39207194.
15. Lebenthal JM, Kontoyiannis PD, Hahn AW, Lim ZD, Rao P, Cheng JP, Chan B, Daw NC, Sheth RA, Karam JA, Tang C, Tannir NM, Msaouel P. Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma. European Urology Oncology 8(2):1-9, 2024. e-Pub 2024. PMID: 39013742.
16. Rose KM, Pham R, Zacharias NM, Ionescu F, Paravathaneni M, Marchetti KA, Sanchez D, Mustasam A, Sandstrom R, Vikram R, Dhillon J, Rao P, Schneider A, Pagliaro L, Alifrangis C, Albersen M, Roussel E, Master VA, Nazha B, Hernandez C, Moses KA, Protzel C, Montgomery J, Angel M, Tobias-Machado M, Spiess PE, Pettaway CA, Chahoud J. Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study. J Natl Cancer Inst 116(6):966-973, 2024. e-Pub 2024. PMID: 38366627.
17. Mbilinyi RH, Msaouel P, Rao P, Karam JA, Tannir NM, Tang C. Radiation Therapy for the Management of Renal Medullary Carcinoma: A Multi-Case Study. Clin Genitourin Cancer 22(3):102065, 2024. e-Pub 2024. PMID: 38556389.
18. Hahn AW, Surasi DS, Viscuse PV, Bathala TK, Wiele AJ, Campbell MT, Zurita AJ, Shah AY, Jonasch E, Gao J, Goswami S, Alhalabi O, Rao P, Sircar K, Tannir NM, Msaouel P. Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy. Oncologist 29(5):392-399, 2024. e-Pub 2024. PMID: 38035767.
19. Zhao J, Guo CC, Rao P. Contemporary Issues in Urothelial Carcinoma of Upper Urinary Tract. Adv Anat Path 31(2):80-87, 2024. e-Pub 2024. PMID: 38009077.
20. Millward, NZ, Segarra, LA, Akagi, K, Fowlkes, NW, Chen, H, Alaniz, A, de la Cerda, C, Pesquera, P, Xi, Y, Wang, J, Chahoud, J, Lu, X, Rao, P, Martínez-Ferrer, M, Pettaway, CA. Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma. Cancers 16(5), 2024. e-Pub 2024. PMID: 38473423.
21. Iorgulescu, JB, Shaw, LK, Rashid, A, Rao, P, Mandayam, S, Patel, KP, Schmeler, KM, Yang, RK, Msaouel, P. Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant. Current Oncology 30(10):9019-9027, 2023. e-Pub 2023. PMID: 37887551.
22. Vokshi, BH, Davidson, G, Tawanaie Pour Sedehi, N, Helleux, A, Rippinger, M, Haller, AR, Gantzer, J, Thouvenin, J, Baltzinger, P, Bouarich, R, Manriquez, V, Zaidi, S, Rao, P, Msaouel, P, Su, X, Lang, H, Tricard, T, Lindner, V, Surdez, D, Kurtz, JE, Bourdeaut, F, Tannir, NM, Davidson, I, Malouf, GG. SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance. Nat Commun 14(1):3034, 2023. e-Pub 2023. PMID: 37236926.
23. Shapiro, DD, Zacharias, NM, Tripathi, DN, Karki, M, Bertocchio, JP, Soeung, M, He, R, Westerman, ME, Gao, J, Rao, P, Lam, TNA, Jonasch, E, Perelli, L, Cheng, EH, Carugo, A, Heffernan, TP, Walker, CL, Genovese, G, Tannir, NM, Karam, JA, Msaouel, P. Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy. Clin Transl Med 13(5):e 1267, 2023. e-Pub 2023. PMID: 37226898.
24. Sarkar, S, Throckmorton, WR, Bingham, R, Msaouel, P, Genovese, G, Slopis, JM, Rao, P, Sadighi, ZS, Herzog, CE. Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2. Current Oncology 30(3):3355-3365, 2023. e-Pub 2023. PMID: 36975468.
25. Zhou, M, Amin, A, Fine, SW, Rao, P, Siadat, F, Shah, RB. Should grade group 1 prostate cancer be reclassified as "non-cancer"? A pathology community perspective. Urol Oncol 41(2):62-64, 2023. e-Pub 2023. PMID: 36428166.
26. Chahoud, J, Millward, NZ, Pham, R, Qiao, W, Guo, M, Lu, X, Alaniz, A, Segarra, LA, Martínez-Ferrer, M, Netto, FG, Pickering, CR, Rao, P, Pettaway, CA. Prognostic Significance of p16 and Its Relationship with Human Papillomavirus Status in Patients with Penile Squamous Cell Carcinoma. Cancers 14(24), 2022. e-Pub 2022. PMID: 36551510.
27. Fuchs, TL, Maclean, F, Turchini, J, Vargas, AC, Bhattarai, S, Agaimy, A, Hartmann, A, Kao, CS, Ellis, C, Bonert, M, Leroy, X, Kunju, LP, Schwartz, LE, Matsika, A, Williamson, SR, Rao, P, Divatia, M, Guarch, R, Algaba, F, Balancin, ML, Zhou, M, Samaratunga, H, Cunha, IW, Brimo, F, Ryan, A, Clouston, D, Aron, M, O’Donnell, M, Chan, E, Hirsch, M, Moch, H, Pang, CY, Cheuk, W, Yin, W, Perry-Keene, J, Yilmaz, A, Chou, A, Clarkson, A, van der Westhuizen, G, Morrison, E, Zwi, J, Hes, O, Trpkov, K, Gill, AJ. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies. Modern Pathology 35(6):836-849, 2022. e-Pub 2022. PMID: 34949766.
28. Msaouel, P, Goswami, S, Thall, PF, Wang, X, Yuan, Y, Jonasch, E, Gao, J, Campbell, M, Shah, AY, Corn, P, Tam, AL, Ahrar, K, Rao, P, Sircar, K, Cohen, L, Basu, S, Duan, F, Jindal, S, Zhang, Y, Chen, H, Yadav, SS, Shazer, R, Der-Torossian, H, Allison, JP, Sharma, P, Tannir, NM. A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy. Science translational medicine 14(641), 2022. e-Pub 2022. PMID: 35442707.
29. Shapiro, DD, Soeung, M, Perelli, L, Dondossola, E, Surasi, DS, Tripathi, DN, Bertocchio, JP, Carbone, F, Starbuck, MW, Van Alstine, ML, Rao, P, Katz, MH, Parker, NH, Shah, AY, Carugo, A, Heffernan, TP, Schadler, KL, Logothetis, CJ, Walker, CL, Wood, CG, Karam, JA, Draetta, G, Tannir, NM, Genovese, G, Msaouel, P. Association of high-intensity exercise with renal medullary carcinoma in individuals with sickle cell trait. Cancers 13(23), 2021. e-Pub 2021. PMID: 34885132.
30. Wilson, NR, Wiele, AJ, Surasi, DS, Rao, P, Sircar, K, Tamboli, P, Shah, AY, Genovese, G, Karam, JA, Wood, CG, Tannir, NM, Msaouel, P. Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma. Clinical Genitourinary Cancer 19(6):e401-e408, 2021. e-Pub 2021. PMID: 34625389.
31. Campbell, M, Matin, S, Tam, AL, Sheth, RA, Ahrar, K, Tidwell, R, Rao, P, Karam, JA, Wood, CG, Tannir, NM, Jonasch, E, Gao, J, Zurita-Saavedra, A, Shah, AY, Jindal, S, Duan, F, Basu, S, Chen, H, Espejo, A, Allison, JP, Yadav, SS, Sharma, P. Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma. Nature communications 12(1), 2021. e-Pub 2021. PMID: 34737281.
32. Pieretti, AC, Westerman, ME, Childs, A, Millward, NZ, Shapiro, DD, Sircar, K, Rao, P, Jonasch, E, Campbell, M, Tannir, NM, Matin, S, Wood, CG, Karam, JA. Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations 39(11):790.e17-790.e23, 2021. e-Pub 2021. PMID: 34301458.
33. Trpkov, K, Hes, O, Williamson, SR, Adeniran, A, Agaimy, A, Alaghehbandan, R, Amin, MB, Argani, P, Chen, YB, Cheng, L, Epstein, J, Cheville, JC, Comperat, EM, Cunha, IW, Gordetsky, JB, Gupta, S, He, H, Hirsch, M, Humphrey, PA, Kapur, P, Kojima, F, Lopez, JI, Maclean, F, Magi-Galluzzi, C, McKenney, J, Mehra, R, Menon, S, Netto, G, Przybycin, CG, Rao, P, Rao, Q, Reuter, VE, Saleeb, RM, Shah, RB, Smith, SC, Tickoo, S, Tretiakova, M, True, LD, Verkarre, V, Wobker, SE, Zhou, M, Gill, AJ. New developments in existing WHO entities and evolving molecular concepts. Modern Pathology 34(7):1392-1424, 2021. e-Pub 2021. PMID: 33664427.
34. Trpkov, K, Williamson, SR, Gill, AJ, Adeniran, A, Agaimy, A, Alaghehbandan, R, Amin, MB, Argani, P, Chen, YB, Cheng, L, Epstein, J, Cheville, JC, Comperat, EM, Cunha, IW, Gordetsky, JB, Gupta, S, He, H, Hirsch, M, Humphrey, PA, Kapur, P, Kojima, F, Lopez, JI, Maclean, F, Magi-Galluzzi, C, McKenney, J, Mehra, R, Menon, S, Netto, G, Przybycin, CG, Rao, P, Rao, Q, Reuter, VE, Saleeb, RM, Shah, RB, Smith, SC, Tickoo, S, Tretiakova, M, True, LD, Verkarre, V, Wobker, SE, Zhou, M, Hes, O. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Modern Pathology 34(6):1167-1184, 2021. e-Pub 2021. PMID: 33526874.
35. Chahoud, J, Gleber-Netto, FO, McCormick, BZ, Rao, P, Lu, X, Guo, M, Morgan, MB, Chu, RA, Martinez-Ferrer, M, Eterovic, AK, Pickering, CR, Pettaway, CA. Whole Exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognositc Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma. Clinc Cancer Res 27(9):2560-2570, 2021. e-Pub 2021. PMID: 33441293.
36. Wiele, AJ, Surasi, DS, Rao, P, Sircar, K, Su, X, Bathala, TK, Shah, AY, Jonasch, E, Cataldo, VD, Genovese, G, Karam, JA, Wood, CG, Tannir, NM, Msaouel, P. Efficacy and safety of bevacizumab plus erlotinib in patients with renal medullary carcinoma. Cancers 13(9), 2021. e-Pub 2021. PMID: 33946504.
37. Chahoud, J, Netto, FG, McCormick, B, Rao, P, Lu, X, Guo, M, Morgan, M, Chu, RA, Martínez-Ferrer, M, Eterovic, AK, Pickering, CR, Pettaway, CA. Whole-exome sequencing in penile squamous cell carcinoma uncovers novel prognostic categorization and drug targets similar to head and neck squamous cell carcinoma A C. Clinical Cancer Research 27(9):2560-2570, 2021. e-Pub 2021. PMID: 33441293.
38. Akgul, M, Williamson, SR, Ertoy, D, Argani, P, Gupta, S, Caliò, A, Reuter, VE, Tickoo, S, Al Ahmadie, H, Netto, G, Hes, O, Hirsch, M, Delahunt, B, Mehra, R, Skala, SL, Osunkoya, AO, Harik, L, Rao, P, Sangoi, AR, Nourieh, M, Zynger, DL, Smith, SC, Nazeer, T, Gumuskaya, B, Kulac, I, Khani, F, Tretiakova, M, Vakar-Lopez, F, Barkan, GA, Molinié, V, Verkarre, V, Rao, Q, Kis, L, Panizo-Santos, A, Farzaneh, T, Magers, MJ, Sanfrancesco, J, Perrino, CM, Gondim, D, Araneta, R, So, JS, Ro, JY, Wasco, M, Hameed, O, Lopez-Beltran, A, Samaratunga, H, Wobker, SE, Melamed, J, Cheng, L, Idrees, MT. Diagnostic approach in TFE3-rearranged renal cell carcinoma. Journal of Clinical Pathology 74(5):291-299, 2021. e-Pub 2021. PMID: 33514585.
39. Kokorovic, A, Duplisea, JJ, Qiao, W, McCormick, B, Adibi, M, Papadopoulos, JN, Ramirez, G, Rao, P, Tamboli, P, Pettaway, CA. Oncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma. Urologic Oncology: Seminars and Original Investigations 39(5):302.e19-302.e27, 2021. e-Pub 2021. PMID: 33612354.
40. Trpkov, K, Williamson, SR, Gill, AJ, Adeniran, A, Agaimy, A, Alaghehbandan, R, Amin, MB, Argani, P, Chen, YB, Cheng, L, Epstein, J, Cheville, JC, Comperat, EM, Cunha, IW, Gordetsky, JB, Gupta, S, He, H, Hirsch, M, Humphrey, PA, Kapur, P, Kojima, F, Lopez, JI, Maclean, F, Magi-Galluzzi, C, McKenney, J, Mehra, R, Menon, S, Netto, G, Przybycin, CG, Rao, P, Rao, Q, Reuter, VE, Saleeb, RM, Shah, RB, Smith, SC, Tickoo, S, Tretiakova, M, True, LD, Verkarre, V, Wobker, SE, Zhou, M, Hes, O. Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia. Modern Pathology 34(5):1037, 2021. e-Pub 2021. PMID: 33727698.
41. Huang, T, Cheng, X, Chahoud, J, Sarhan, A, Tamboli, P, Rao, P, Guo, M, Manyam, GC, Zhang, L, Xiang, Y, Han, L, Shang, X, Deng, P, Luo, Y, Lu, X, Feng, S, Martínez-Ferrer, M, Wang, YA, DePinho, RA, Pettaway, CA, Lu, X. Effective combinatorial immunotherapy for penile squamous cell carcinoma. Nature communications 11(1), 2020. e-Pub 2020. PMID: 32358507.
42. Collins, K, Hwang, M, Hamza, A, Rao, P. Prevalence of high-risk human papillomavirus in primary squamous cell carcinoma of urinary bladder. Pathology Research and Practice 216(9), 2020. e-Pub 2020. PMID: 32825952.
43. Msaouel, P, Malouf, GG, Su, X, Yao, H, Tripathi, DN, Soeung, M, Gao, J, Rao, P, Coarfa, C, Creighton, CJ, Bertocchio, JP, Kunnimalaiyaan, S, Multani, AS, Blando, J, He, R, Shapiro, DD, Perelli, L, Srinivasan, S, Carbone, F, Pilie, PG, Karki, M, Seervai, RN, Vokshi, BH, Lopez-Terrada, D, Cheng, EH, Tang, X, Lu, W, Wistuba, II, Thompson, T, Davidson, I, Giuliani, V, Schlacher, K, Carugo, A, Heffernan, TP, Sharma, P, Karam, JA, Wood, CG, Walker, CL, Genovese, G, Tannir, NM. Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma. Cancer cell 37(5):720-734.e13, 2020. e-Pub 2020. PMID: 32359397.
44. Ruiz-Cordero, R, Rao, P, Li, L, Qi, Y, Atherton, D, Peng, B, Singh, RR, Kim, T, Kawakami, F, Routbort, MJ, Alouch, N, Chow, CW, Tang, X, Lu, W, Brimo, F, Matin, S, Wood, CG, Tannir, NM, Wistuba, II, Chen, K, Wang, J, Medeiros, LJ, Karam, JA, Tamboli, P, Sircar, K. Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma. Modern Pathology 32(11):1698-1707, 2019. e-Pub 2019. PMID: 31231128.
45. Schvartsman, G, Carneiro, AP, Filippi, RZ, Rao, P, Msaouel, P. Rapid Deep Responses With Nivolumab Plus Ipilimumab in Papillary Renal Cell Carcinoma With Sarcomatoid Dedifferentiation. Clinical Genitourinary Cancer 17(4):315-318, 2019. e-Pub 2019. PMID: 31213412.
46. Lim, A, Rao, P, Matin, S. Lynch syndrome and urologic malignancies. Current opinion in urology 29(4):357-363, 2019. e-Pub 2019. PMID: 31045926.
47. Fatheree, LA, Fitzgibbons, PL, Rao, P, Thomas, NE, Zhou, M, Tambouret, RH. Localized Renal Masses: Comment on Recent American Urological Association Guideline. Archives of Pathology and Laboratory Medicine 143(6):659, 2019. e-Pub 2019. PMID: 31121111.
48. Carugo, A, Minelli, R, Sapio, L, Soeung, M, Carbone, F, Robinson, FS, Tepper, JM, Chen, Z, Lovisa, S, Svelto, M, Amin, S, Srinivasan, S, Del Poggetto, E, Loponte, S, Puca, F, Dey, P, Malouf, GG, Su, X, Li, L, Lopez-Terrada, D, Rakheja, D, Lazar, A, Netto, G, Rao, P, Sgambato, A, Maitra, A, Tripathi, DN, Walker, CL, Karam, JA, Heffernan, TP, Viale, A, Roberts, CW, Msaouel, P, Tannir, NM, Draetta, G, Genovese, G. p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors. Cancer cell 35(2):204-220.e9, 2019. e-Pub 2019. PMID: 30753823.
49. Msaouel, P, Hong, AL, Mullen, EA, Atkins, MB, Walker, CL, Lee, CH, Carden, MA, Genovese, G, Linehan, WM, Rao, P, Merino, M, Grodman, H, Dome, JS, Fernandez, CV, Geller, JI, Apolo, AB, Daw Bitar, N, Hodges, HC, Moxey-Mims, M, Wei, D, Bottaro, D, Staehler, M, Karam, JA, Rathmell, WK, Tannir, NM. Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma. Clinical Genitourinary Cancer 17(1):1-6, 2019. e-Pub 2019. PMID: 30287223.
50. Wang, G, Rao, P. Succinate dehydrogenase-deficient renal cell carcinoma. Archives of Pathology and Laboratory Medicine 142(10):1284-1288, 2018. e-Pub 2018. PMID: 30281364.
51. Williamson, SR, Rao, P, Hes, O, Epstein, J, Smith, SC, Picken, MM, Zhou, M, Tretiakova, M, Tickoo, S, Chen, YB, Reuter, V, Fleming, S, Maclean, F, Gupta, N, Kuroda, N, Delahunt, B, Mehra, R, Przybycin, CG, Cheng, L, Eble, JN, Grignon, D, Moch, H, Lopez, JI, Kunju, LP, Tamboli, P, Srigley, JR, Amin, MB, Martignoni, G, Hirsch, M, Bonsib, S, Trpkov, K. Challenges in pathologic staging of renal cell carcinoma. American Journal of Surgical Pathology 42(9):1253-1261, 2018. e-Pub 2018. PMID: 29878933.
52. Metcalfe, MJ, Petros, FG, Rao, P, Mork, ME, Xiao, L, Broaddus, R, Matin, S. Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma. Journal of Urology 199(1):60-65, 2018. e-Pub 2018. PMID: 28797715.
53. Ohe, C, Smith, SC, Sirohi, D, Divatia, M, De Peralta-Venturina, M, Paner, GP, Agaimy, A, Amin, M, Argani, P, Chen, YB, Cheng, L, Colecchia, M, Comperat, EM, Cunha, IW, Epstein, J, Gill, AJ, Hes, O, Hirsch, M, Jochum, W, Kunju, LP, Maclean, F, Magi-Galluzzi, C, McKenney, J, Mehra, R, Nesi, G, Osunkoya, AO, Picken, MM, Rao, P, Reuter, V, De Oliveira Salles, PG, Schultz, L, Tickoo, S, Tomlins, S, Trpkov, K, Amin, MB. Reappraisal of Morphologic Differences between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma. American Journal of Surgical Pathology 42(3):279-292, 2018. e-Pub 2018. PMID: 29309300.
54. Murugan, P, Rao, P, Tamboli, P, Czerniak, BA, Guo, CC. Primary Ewing Sarcoma / Primitive Neuroectodermal Tumor of the Kidney. Pathology and Oncology Research 24(1):153-159, 2018. e-Pub 2018. PMID: 28429277.
55. Shah, AY, Karam, JA, Malouf, GG, Rao, P, Lim, ZD, Jonasch, E, Xiao, L, Gao, J, Vaishampayan, U, Heng, DY, Plimack, ER, Guancial, E, Fung, C, Lowas, SR, Tamboli, P, Sircar, K, Matin, S, Rathmell, WK, Wood, CG, Tannir, NM. Management and outcomes of patients with renal medullary carcinoma. BJU international 120(6):782-792, 2017. e-Pub 2017. PMID: 27860149.
56. Sirohi, D, Smith, SC, Ohe, C, Colombo, P, Divatia, M, Dragoescu, E, Rao, P, Hirsch, M, Chen, YB, Mehra, R, Amin, MB. Renal cell carcinoma, unclassified with medullary phenotype. Human Pathology 67:134-145, 2017. e-Pub 2017. PMID: 28716439.
57. Gupta, S, Johnson, SH, Vasmatzis, G, Porath, B, Rustin, JG, Rao, P, Costello, BA, Leibovich, BC, Houston Thompson, R, Cheville, JC, Sukov, WR. TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma. Modern Pathology 30(7):998-1012, 2017. e-Pub 2017. PMID: 28338654.
58. Kalra, S, Verma, J, Atkinson, BJ, Matin, S, Wood, CG, Karam, JA, Lin, S, Satcher, R, Tamboli, P, Sircar, K, Rao, P, Corn, P, Tannir, NM, Jonasch, E. Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era. Clinical Genitourinary Cancer 15(3):363-370, 2017. e-Pub 2017. PMID: 28216278.
59. Katabathina, VS, Vikram, R, Olaoya, A, Paspulati, RM, Nicolas, MM, Rao, P, Zaheer, A, Prasad, S. Neuroendocrine neoplasms of the genitourinary tract in adults. Abdominal Radiology 42(5):1472-1484, 2017. e-Pub 2017. PMID: 27942847.
60. Reddy, JP, Pettaway, CA, Levy, LB, Pagliaro, LC, Tamboli, P, Rao, P, Jayaratna, IS, Hoffman, K. Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma. BJU international 119(4):591-597, 2017. e-Pub 2017. PMID: 27753187.
61. Biebighauser, KC, Gao, J, Rao, P, Landon, G, Pagliaro, LC, Dinney, CP, Karam, JA, Navai, N. Non-seminomatous germ cell tumor with bone metastasis only at diagnosis. Asian Journal of Urology 4(2):124-127, 2017. e-Pub 2017. PMID: 29264217.
62. Kawakami, F, Rao, P, Tamboli, P, Wood, CG, Karam, JA. Study of the Kidney Tumor-Parenchymal Interface after Neoadjuvant Treatment with Axitinib for Locally Advanced Clear Cell Renal Cell Carcinoma. Journal of Urology 197(3):559-565, 2017. e-Pub 2017. PMID: 27678298.
63. Teegavarapu, PS, Rao, P, Matrana, MR, Cauley, DH, Wood, CG, Patel, S, Tannir, NM. Outcomes of Adults with Ewing Sarcoma Family of Tumors (ESFT) of the Kidney. American Journal of Clinical Oncology: Cancer Clinical Trials 40(2):189-193, 2017. e-Pub 2017. PMID: 25222071.
64. Tu, S, Bilen, MA, Hess, KR, Broaddus, R, Kopetz, S, Wei, C, Pagliaro, LC, Karam, JA, Ward, JF, Wood, CG, Rao, P, Tu, ZH, General, R, Chen, AH, Nieto, Y, Yeung, SJ, Lin, S, Logothetis, CJ, Pisters, LL. Intratumoral heterogeneity. Cancer 122(12):1836-1843, 2016. e-Pub 2016. PMID: 27018785.
65. LeRoy, MA, Rao, P. Angiomyolipoma with Epithelial Cysts. Arch Pathol Lab Med 140(6):594-597, 2016. e-Pub 2016. PMID: 27232352.
66. Zhou, L, Liu, X, Sun, M, Zhang, X, German, P, Bai, S, Ding, Z, Tannir, NM, Wood, CG, Matin, S, Karam, JA, Tamboli, P, Sircar, K, Rao, P, Rankin, EB, Laird, DA, Hoang, A, Walker, CL, Giaccia, AJ, Jonasch, E. Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene 35(21):2687-2697, 2016. e-Pub 2016. PMID: 26364599.
67. Kalra, S, Atkinson, BJ, Matrana, MR, Matin, S, Wood, CG, Karam, JA, Tamboli, P, Sircar, K, Rao, P, Corn, P, Tannir, NM, Jonasch, E. Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases. BJU international 117(5):761-765, 2016. e-Pub 2016. PMID: 26032863.
68. Tannir, NM, Jonasch, E, Albiges, L, Altinmakas, E, Ng, CS, Matin, S, Wang, X, Qiao, W, Dubauskas Lim, Z, Tamboli, P, Rao, P, Sircar, K, Karam, JA, McDermott, DF, Wood, CG, Choueiri, TK. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN). European urology 69(5):866-874, 2016. e-Pub 2016. PMID: 26626617.
69. Lanza, DG, Dawson, EP, Rao, P, Heaney, J. Misexpression of cyclin D1 in embryonic germ cells promotes testicular teratoma initiation. Cell Cycle 15(7):919-930, 2016. e-Pub 2016. PMID: 26901436.
70. Bilen, MA, Hess, KR, Campbell, M, Wang, J, Broaddus, R, Karam, JA, Ward, JF, Wood, CG, Choi, S, Rao, P, Zhang, M, Naing, A, General, R, Cauley, DH, Lin, S, Logothetis, CJ, Pisters, LL, Tu, S. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis. Oncotarget 7(52):86280-86289, 2016. e-Pub 2016. PMID: 27861143.
71. Liu, X, Hoang, A, Zhou, L, Kalra, S, Yetil, A, Sun, M, Ding, Z, Zhang, X, Bai, S, German, P, Tamboli, P, Rao, P, Karam, JA, Wood, CG, Matin, S, Zurita-Saavedra, A, Bex, A, Griffioen, AW, Gao, J, Sharma, P, Tannir, NM, Sircar, K, Jonasch, E. Resistance to antiangiogenic therapy is associated with an immunosuppressive tumor microenvironment in metastatic Renal cell carcinoma. Cancer Immunology Research 3(9):1017-1029, 2015. e-Pub 2015. PMID: 26014097.
72. Aron, M, Chang, E, Herrera, L, Hes, O, Hirsch, M, Comperat, EM, Camparo, P, Rao, P, Picken, MM, Michal, M, Montironi, R, Tamboli, P, Monzon, FA, Amin, MB. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease. American Journal of Surgical Pathology 39(7):873-888, 2015. e-Pub 2015. PMID: 25970682.
73. Amin, MB, Smith, SC, Reuter, V, Epstein, J, Grignon, D, Hansel, DE, Lin, O, McKenney, J, Montironi, R, Paner, GP, Al Ahmadie, H, Algaba, F, Ali, S, Alvarado-Cabrero, I, Bubendorf, L, Cheng, L, Cheville, JC, Kristiansen, G, Cote, R, Delahunt, B, Eble, JN, Genega, EM, Gulmann, C, Hartmann, A, Langner, C, Lopez-Beltran, A, Magi-Galluzzi, C, Jorda, M, Netto, G, Oliva, E, Rao, P, Ro, JY, Srigley, JR, Tickoo, S, Tsuzuki, T, Umar, SA, Van Der Kwast, T, Young, RH, Soloway, M. Update for the practicing pathologist. Modern Pathology 28(5):612-630, 2015. e-Pub 2015. PMID: 25412849.
74. Karam, JA, Wood, CG, Compton, ZR, Rao, P, Vikram, R, Ahrar, K, Matin, S. Salvage surgery after energy ablation for renal masses. BJU international 115(1):74-80, 2015. e-Pub 2015. PMID: 24656119.
75. Rao, P, Tamboli, P, Fillman, EP, Meis, JM. Primary intra-renal desmoplastic small round cell tumor. Pathology Research and Practice 210(12):1130-1133, 2014. e-Pub 2014. PMID: 24953786.
76. Wassal, EY, Habra, MA, Vicens, R, Rao, P, Elsayes, KM. Ovarian thecal metaplasia of the adrenal gland in association with Beckwith-Wiedemann Syndrome. World J Radiol 6(12):919-923, 2014. e-Pub 2014. PMID: 25550997.
77. Rao, P, Colen, R, Bruner, JM, Meis, JM. Extraskeletal myxoid chondrosarcoma presenting as an intradural spinal mass. Rare Tumors 6(4):150-153, 2014. e-Pub 2014. PMID: 25568751.
78. Rao, P, Monzon, FA, Jonasch, E, Matin, S, Tamboli, P. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome - Clinicopathological features and comparative genomic analysis of 3 cases. Human Pathology 45(9):1966-1972, 2014. e-Pub 2014. PMID: 25081542.
79. Subbiah, V, Meric-Bernstam, F, Mills, GB, Shaw, KR, Bailey, AM, Rao, P, Ward, JF, Pagliaro, LC. Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial. Journal of Hematology and Oncology 7(1), 2014. e-Pub 2014. PMID: 25085632.
80. Amin, MB, Smith, SC, Eble, JN, Rao, P, Choi, WW, Tamboli, P, Young, RH. Glandular neoplasms of the urachus. American Journal of Surgical Pathology 38(8):1033-1045, 2014. e-Pub 2014. PMID: 25025366.
81. Amin, MB, Smith, SC, Agaimy, A, Argani, P, Comperat, EM, Delahunt, B, Epstein, J, Eble, JN, Grignon, D, Hartmann, A, Hes, O, Hirsch, M, Jimenez, R, Kunju, LP, Martignoni, G, McKenney, J, Moch, H, Montironi, R, Paner, GP, Rao, P, Srigley, JR, Tickoo, S, Reuter, V. Collecting duct carcinoma versus renal medullary carcinoma. American Journal of Surgical Pathology 38(7):871-874, 2014. e-Pub 2014. PMID: 24805860.
82. Paner, GP, Annaiah, C, Gulmann, C, Rao, P, Ro, JY, Hansel, DE, Shen, SS, Lopez-Beltran, A, Aron, M, Luthringer, DJ, De Peralta-Venturina, M, Cho, Y, Amin, MB. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder. Human Pathology 45(7):1473-1482, 2014. e-Pub 2014. PMID: 24780825.
83. Ananthanarayanan, V, Pan, Y, Tretiakova, M, Amin, MB, Cheng, L, Epstein, J, Grignon, D, Hansel, DE, Jimenez, R, McKenney, J, Montironi, R, Oliva, E, Osunkoya, AO, Rao, P, Reuter, V, Ro, JY, Shen, SS, Srigley, JR, Tsuzuki, T, Yao, JL, Antic, T, Haber, M, Taxy, JB, Paner, GP. Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a). American Journal of Surgical Pathology 38(2):167-175, 2014. e-Pub 2014. PMID: 24145655.
84. Teegavarapu, PS, Rao, P, Matrana, MR, Cauley, DH, Wood, CG, Tannir, NM. Neuroendocrine tumors of the kidney. Clinical Genitourinary Cancer 12(6):422-427, 2014. e-Pub 2014. PMID: 25088468.
85. Burch-Smith, R, Tannir, NM, Resetkova, E, Tamboli, P, Rao, P. Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma. Chinese Journal of Cancer 33(7):351-355, 2014. e-Pub 2014. PMID: 24589208.
86. Ferreira, EF, Turturro, F, Rao, P, Matin, S. Malignant epithelioid angiomyolipoma. Clinical Genitourinary Cancer 11(4):e1-e5, 2013. e-Pub 2013. PMID: 23791549.
87. Som, A, Xiao, L, Zhu, R, Guo, CC, Xiao, L, Rao, P, Efstathiou, E, Matin, A, Tu, S. Clinically atypical seminomas with yolk sac tumor features. Canadian Journal of Urology 20(4):6860-6867, 2013. e-Pub 2013. PMID: 23930614.
88. Karam, JA, Ahrar, K, Vikram, R, Romero, C, Jonasch, E, Tannir, NM, Rao, P, Wood, CG, Matin, S. Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results. BJU international 111(6):997-1005, 2013. e-Pub 2013. PMID: 23510233.
89. Gulmann, C, Paner, GP, Parakh, RS, Hansel, DE, Shen, SS, Ro, JY, Annaiah, C, Lopez-Beltran, A, Rao, P, Arora, K, Cho, Y, Herrera-Hernandez, L, Alsabeh, R, Amin, MB. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Human Pathology 44(2):164-172, 2013. e-Pub 2013. PMID: 22995333.
90. Rao, P, Lahat, G, Arnold, C, Gavino, AC, Lahat, S, Hornick, JL, Chelouche Lev, D, Lazar, A. Angiosarcoma. American Journal of Dermatopathology 35(4):432-437, 2013. e-Pub 2013. PMID: 23689692.
91. Sircar, K, Rao, P, Jonasch, E, Monzon, FA, Tamboli, P. Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features. Chinese Journal of Cancer 32(6):303-311, 2013. e-Pub 2013. PMID: 23237216.
92. Richey, SL, Rao, P, Wood, CG, Patel, S, Tannir, NM. Metastatic extraosseous ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney. Clinical Genitourinary Cancer 10(3):210-212, 2012. e-Pub 2012. PMID: 22503609.
93. Rao, P, Tannir, NM, Tamboli, P. Expression of OCT3/4 in renal medullary carcinoma represents a potential diagnostic pitfall. American Journal of Surgical Pathology 36(4):583-588, 2012. e-Pub 2012. PMID: 22301499.
94. Matrana, MR, Ng, CS, Rao, P, Lim, ZD, Tannir, NM. Chromophobe renal cell carcinoma with sarcomatoid dedifferentiation treated with Pazopanib. Clinical Genitourinary Cancer 9(2):137-139, 2011. e-Pub 2011. PMID: 21831725.
95. Colombo, C, Bolshakov, S, Hajibashi, S, Lopez-Terrada, L, Wang, W, Rao, P, Benjamin, RS, Lazar, A, Chelouche Lev, D. 'Difficult to diagnose' desmoid tumours. Histopathology 59(2):336-340, 2011. e-Pub 2011. PMID: 21884214.
96. Varghese, J, Ayala-Ramirez, M, Rich, TA, Rohren, E, Rao, P, Jimenez, C. Novel germline SDHD mutation. Familial Cancer 10(2):365-371, 2011. e-Pub 2011. PMID: 21318381.
97. Sakharpe, A, Lahat, G, Gulamhusein, T, Liu, P, Nguyen, SB, Zhang, P, Belousov, R, Young, E, Xie, XB, Rao, P, Hornick, JL, Lazar, A, Pollock, RE, Chelouche Lev, D. Epithelioid sarcoma and unclassified sarcoma with epithelioid features. Oncologist 16(4):512-522, 2011. e-Pub 2011. PMID: 21357725.
98. Weaver, J, Rao, P, Goldblum, J, Joyce, MJ, Turner, S, Lazar, A, López-Terada, D, Tubbs, RR, Rubin, BP. Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma. Modern Pathology 23(10):1301-1306, 2010. e-Pub 2010. PMID: 20495536.
99. Brown, JG, Folpe, AL, Rao, P, Lazar, A, Paner, GP, Gupta, R, Parakh, RS, Cheville, JC, Amin, MB. Primary vascular tumors and tumor-like lesions of the kidney. American Journal of Surgical Pathology 34(7):942-949, 2010. e-Pub 2010. PMID: 20534992.
100. Rao, P, Fuller, GN, Prieto, V. Expression of SOX-9 in metastatic melanoma-a potential diagnostic pitfall. American Journal of Dermatopathology 32(3):262-266, 2010. e-Pub 2010. PMID: 20098296.
101. Rao, P, Balzer, BL, Lemos, BD, Liégeois, N, McNiff, JM, Nghiem, P, Prieto, V, Smith, MT, Smoller, BR, Wick, MR, Frishberg, DP. Protocol for the examination of specimens from patients with merkel cell carcinoma of the skin. Archives of Pathology and Laboratory Medicine 134(3):341-344, 2010. e-Pub 2010. PMID: 20196661.
102. Frishberg, DP, Balch, CM, Balzer, BL, Neil Crowson, A, Didolkar, MS, McNiff, JM, Perry, RR, Prieto, V, Rao, P, Smith, MT, Smoller, BR, Wick, MR. Protocol for the examination of specimens from patients with melanoma of the skin. Archives of Pathology and Laboratory Medicine 133(10):1560-1567, 2009. e-Pub 2009. PMID: 19792045.
103. Rao, P, Pinheiro, N, Franco, M, Ra, S, Costa, H, Manzano, J, Paner, GP, Silva, EG, Amin, MB. Pseudomyxoma peritonei associated with primary mucinous borderline tumor of the renal pelvicalyceal system. Archives of Pathology and Laboratory Medicine 133(9):1472-1476, 2009. e-Pub 2009. PMID: 19722758.
104. Nigwekar, P, Tamboli, P, Amin, MB, Osunkoya, AO, Ben-Dor, D, Amin, MB. Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases. Am J Surg Pathol 33(3):417-424, 2009. e-Pub 2009. PMID: 19011563.
105. Nigwekar, P, Amin, MB. The many faces of urothelial carcinoma: an update with an emphasis on recently described variants. Adv Anat Pathol 15(4):218-233, 2008. e-Pub 2008. PMID: 18580098.
106. Zhang, M, Nigwekar, P, Castaneda, B, Hoyt, K, Joseph, JV, di Sant'Agnese, A, Messing, EM, Strang, JG, Rubens, DJ, Parker, KJ. Quantitative characterization of viscoelastic properties of human prostate correlated with histology. Ultrasound Med Biol 34(7):1033-1042, 2008. e-Pub 2008. PMID: 18258350.
107. Hoyt, K, Castaneda, B, Zhang, M, Nigwekar, P, di Sant'Agnese, PA, Joseph, JV, Strang, J, Rubens, DJ, Parker, KJ. Tissue elasticity properties as biomarkers for prostate cancer. Cancer Biomark 4(4-5):213-225, 2008. e-Pub 2008. PMID: 18957712.
108. Zhang, M, Castaneda, B, Wu, Z, Nigwekar, P, Joseph, JV, Rubens, DJ, Parker, KJ. Congruence of imaging estimators and mechanical measurements of viscoelastic properties of soft tissues. Ultrasound Med Biol 33(10):1617-1631, 2007. e-Pub 2007. PMID: 17604902.
109. Taylor, LS, Rubens, DJ, Porter, BC, Wu, Z, Baggs, RB, di Sant'Agnese, PA, Nadasdy, G, Pasternack, D, Messing, EM, Nigwekar, P, Parker, KJ. Prostate cancer: three-dimensional sonoelastography for in vitro detection. Radiology 237(3):981-985, 2005. e-Pub 2005. PMID: 16251396.
110. Kumar, A, Surowiec, S, Nigwekar, P, Illig, KA. Masson's intravascular hemangioma masquerading as effort thrombosis. J Vasc Surg 40(4):812-814, 2004. e-Pub 2004. PMID: 15472612.

Review Articles

1. Blackmur, JP, van der Mijn, JC, Warren, AY, Browning, L, Burgers, F, Hirsch, M, Kapur, P, Mehra, R, Rao, P, Signoretti, S, Bex, A, Stewart, GD, van Montfoort, ML, Jones, JO. Assessing pathological response to neoadjuvant therapy in renal cell carcinoma. The lancet oncology 26(10):e536-e546, 2025. e-Pub 2025. PMID: 41038202.
2. Lobo A, Collins K, Kaushal S, Acosta AM, Akgul M, Adhya AK, Al-Ahmadie HA, Al-Obaidy KI, Amin A, Amin MB, Aron M, Balzer BL, Biswal R, Mohanty S, Browning L, Chakrabarti I, Cima L, Cimadamore A, Desai S, Dhillon J, Deshwal A, Diego GG, Diwaker P, Galea LA, Magi-Galluzzi C, Giannico GA, Gupta NS, Haider A, Hirsch MS, Iczkowski KA, Arora S, Jain E, Jain D, Jha S, Kandukuri S, Kao CS, Kryvenko ON, Kumar RM, Kumari N, Kunju LP, Kuthi L, Lobo J, Lopez JI, Luthringer DJ, Maclean F, Manini C, Mannan R, Martos MG, Mehra R, Menon S, Mishra P, Moch H, Montironi R, Baisakh MR, Netto GJ, Nigam LK, Osunkoya AO, Pagliuca F, Paner GP, Panizo A, Parwani AV, Picken MM, Prendeville S, Przybycin CG, Purkait S, Queipo FJ, Rao BV, Rao P, Reuter VE, Sancheti S, Sangoi AR, Sardana R, Satturwar S, Shah RB, Sharma S, Dixit M, Verma M, Sirohi D, Smith SC, Soni S, Sundaram S, Swain M, Tretiakova M, Trpkov K, MunizUnamunzaga G, Zhou M, Williamson SR, Lopez-Beltran A, Cheng L, Mohanty SK. Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature. Histopathology 85(5):748-759, 2024. e-Pub 2024. PMID: 39075659.
3. Hwang, MJ, Brennan, P, Monge, BM, Alkamachi, B, Rohra, P, Peshoff, MM, Sharma, P, Sircar, K, Tamboli, P, Rao, P. Best practices and recommendations for grossing and reporting of post-immunotherapy nephrectomy specimens. Diagnostic Histopathology 30(5):275-281, 2024. e-Pub 2024.

Abstracts

1. Simone A, Carmon L, Rao P, Cichocki M, Yuan K, Blecha M, Bechara CF, Soult MC. Routine Use of Indwelling Urinary Catheters During Endovascular Abdominal Aortic Aneurysm Repair is Not Necessary. Vasc Endovascular Surg 59(3):271-276, 2025. e-Pub 2025. PMID: 39402717.
2. Lebenthal JM, Kontoyiannis PD, Hahn AW, Lim ZD, Rao P, Cheng JP, Chan B, Daw NC, Sheth RA, Karam J, Tang C, Tannir NM, Msaouel P. Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma. Eur Urol Oncol 8(2):315-323, 2025. e-Pub 2025. PMID: 39013742.
3. Shah RB, Paner GP, Cheng L, Marzo AMD, Magi-Galluzzi C, Varma M, Zhou M, Amin A, Amin MB, Aron M, Cunha IW, Epstein JI, Fine SW, Haider A, Iczkowski KA, Kench JG, Kunju LP, Mohanty SK, Montironi R, Netto GJ, Kristiansen G, Pan CC, Rao P, Srigley JR, Sauter G, Tan PH, Tsuzuki T, van der Kwast TH, van Leenders GJ, Kristiansen G. Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer. Eur Urol 88(1):1-3, 2025. e-Pub 2025. PMID: 40102113.
4. Rao P, Karki M, Blum KA, Bertocchio J, He R, Tripathi DN, Zacharias NM, Lebenthal JM, Sheth RA, Rao P, Genovese G, Lu Z, Bast RC, Ingram DR, Lazcano R, Wani KM, Wang W, Lazar AJ, Tannir NM, Walker CL, Coarfa C, Msaouel P. CA-125 as a Biomarker in Renal Medullary Carcinoma. Clin Cancer Res 31(6):1057-1068, 2025. e-Pub 2025. PMID: 39836407.
5. Li RD, O’Meara R, Rao P, Kang I, Soult MC, Bechara CF, Blecha AM. Hospital Volume and Social Determinants of Health Do Not Impact Outcomes in Fenestrated Visceral Segment Endovascular Aortic Repair for Patients Treated at VQI Centers. Vasc Endovascular Surg:1-10, 2025. e-Pub 2025. PMID: 40127376.
6. Mohanty, S, Paner, G, Lobo, A, Parwani, A, Sangoi, A, Delahunt, B, Manini, C, Luthringer, D, Sirohi, D, Midha, D, Maclean, F, Giannico, G, Martignoni, G, Al-Ahmadie, H, Moch, H, Gandhi, J, Srigley, J, Epstein, J, Lopez, J, Trpkov, K, Cheng, L, Browning, L, Akgul, M, Aron, M, Picken, M, Tretiakova, M, Hirsch, M, Varma, M, Kuroda, N, Gupta, N, Tamboli, P, Rao, P, Mehra, R, Desai, S, Menon, S, Williamson, S, Kaushal, S, Jha, S, Kandukuri, S, Rao, BC, Amin, M. Uropathologists' Perspectives on Utilization of Key Morphologic and Molecular Parameters in Urothelial, Renal, and Prostatic Cancers based on Clinical Practice Guidelines:595, 639-640, 2025.
7. Kingsley Ebare, Gang Wang, Qi Wang, Varsha Nair, Sathwik Iyer, Rao P, Pheroze Tamboli, Kasthuri Kannan, Jing Wang, Jose Karam, Maryam Soleimani, Krishna Bhat, Kanishka Sircar. Spatial Transcriptomic Evaluation of Tumor And Tumor Microenvironment of Renal Cell Carcinoma With Respect To Regional Histology And Response To Immunotherapy. USCAP 113th Annual Meeting, 2025.
8. Dhillon A, Lobo A, Akgul M, Acosta AM, Chumbalkar V, Vosoughi A, Xu H, Al-Ahmadie HA, Al-Obaidy KI, Amin MB, Aron M, Arora S, Ayyanar P, Bakshi N, Balzer BL, Bardia A, Baweja P, Chakrabarti I, Cheng L, Cima L, Colecchia M, Collins K, Comperat EM, Das D, Dixit M, Downes MR, Elhence PA, Epstein J, Galea LA, Gandhi JS, Giannico GA, Gordetsky JB, Gupta G, Gupta N, Haider A, Hansel DE, Hartmann A, Ho-Yen C, Iczkowski KA, Jain E, Jain R, Jha S, Kao C, Kaushal S, van Leenders GJ, lenka K, Lopez JI, Lopez-Beltran A, Luthringer DJ, C, Maclean F, Magi-Galluzzi C, Malik V, Manini C, Martignoni G, Mehta BA, Menon S, Misra S, Mohanty S, Montironi R, Nayak S, Nguyen JK, Ntala C, Oliveira P, Osunkoya A, Patil S, Picken MM, Prachi D, Pradhan D, Prendeville S, Queipo FJ, Quiroga-Garza GM, Rao B, Rao P, Raspollini MR, Sabnis SR, Sancheti S, Sanchez DF, Sarungbam J, SATARKAR R, Satturwar S, Ali Sayyed NKM, Shah RB, Sharma I, Sharma N, Sharma S, Sirohi D, Sobti P, Soni S, Sreeram S, Sundaram S, Tamboli P, Tanveer N, Tickoo SK, Tiwari A, Tomar R, Tretiakova M, Trpkov K, Tsuzuki T, Warrick J, Zhou M, Sangoi AR, Williamson SR, Mohanty SK. Current Reporting Trends, Practices, and Resource Utilization in Penile Cancer. USCAP 113th Annual Meeting, 2025.
9. Sangoi AR, Akgul M, Mubeen A, Humble RM, Acosta AM, Amin MB, Aron M, Brimo F, Chan E, Cheng L, Cheville JC, Collins K, Cornejo KM, Dhillon J, Downes MR, Epstein J, Hirsch MS, Kapur P, Lobo A, Mehra R, Mohanty SK, Netto GJ, Osunkoya A, Paner GP, Rao P, Saleeb R, Shah RB, Shen S, Smith SC, Tickoo SK, Tretiakova M, Trpkov K, Wobker SE, Tamboli P, Zynger DL, Williamson SR. Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinomas Among Genitourinary Pathologists. USCAP 113th Annual Meeting, 2025.
10. Wu DJ, Akgul M, Williamson SR, Acosta AM, Al-Obaidy KI, Amin MB, Berney D, Brimo F, Cheng L, Colecchia M, Comperat EM, Cornejo KM, Dhillon J, Downes MR, Epstein J, Hirsch MS, Jimenez RE, Lobo A, Kaushal S, Lopez-Beltran A, Mohanty SK, Mehra R, Paner GP, Rao P, Reuter VE, Shah RB, Shen S, Smith SC, Tretiakova M, Trpkov K, Wobker SE, Tamboli P, Zynger DL, Sangoi AR. Interobserver Reproducibility of Hilar Soft Tissue Invasion in Testicular Germ Cell Tumors Among Genitourinary Pathologists. USCAP 113th Annual Meeting, 2025.
11. Kumar G, Ruiz-Cordero R, Akgul M, Murugan P, Shen S, Brimo F, Rao P, Tamboli P, Creighton C, Bhat K, Karam J, Kannan K, Sircar K. Gene Expression Signatures From FFPE Kidney Tumor Samples Can Predict For Clinically Indolent Renal Oncocytic Tumors. USCAP 113th Annual Meeting, 2025.
12. Rao P, Gao J, Basu S, Shapiro DD, Karam JA, Tidwell RS, Ahrar K, Campbell MT, Shen Y, Trevino AE, Mayer AT, Espejo AB, Seua C, Macaluso MD, Chen Y, Liu W, He Z, Yadav SS, Wang Y, Rao P, Zhao L, Zhang J, Jindal S, Tannir NM, Futreal A, Wang L, Sharma P. Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma. Nature communications 16(1), 2025. e-Pub 2025. PMID: 39984485.
13. Campbel, M, Rao, P. CABOSUN II:, 2023.
14. Mohanty, S, Lobo, A, Parwani, A, Adhya, A, Sangoi, A, Kulkarni, B, Delahunt, B, Przybycin, C, Manini, C, Luthringer, D, Sirohi, D, Midha, D, Jain, E, Maclean, F, Giannico, G, Paner, G, Martignoni, G, Al-Ahmadie, H, Moch, H, McKenney, J, Epstein, J, Lopez, J, Trpkov, K, Cheng, L, Browning, L, Akgul, M, Amin, M, Baisakh, M, Aron, M, Picken, M, Tretiakova, M, Hirsch, M, Zhou, M, Kuroda, N, Pattnaik, N, Gupta, N, Hes, O, Rao, P, Shah, R, Mehra, R, Fine, S, Desai, S, Sancheti, S, Menon, S, Wobker, S, Tickoo, S, Kaushal, S, Jha, S, Kandukuri, S, Sharma, S, Smith, S, Mitra, S, Reuter, V, Rao, BV, Chen, YB, Williamson, S. The Current State of Emerging Renal Oncolytic Neoplasms: A Survey of Urologic Pathologists, 2022.
15. Zacharias, N, Rao, P, Pettaway, C. Metabolic Hallmarks of Rare Renal Cell Carcinoma Patient-derived Xenograft models, 2022.
16. Westerman, ME, Childs, A, Shapiro, DD, Pieretti, AC, Sircar, K, Rao, P, Matin, SF, Karam, JA, Wood, CG. Outcomes of High Risk Chromophobe Renal Cell Carcinoma:, 2021.
17. Shapiro, DD, Zacharias, NM, Tripathi, D, Bertocchio, JP, Soeung, M, Rao, P, Walker, C, Genovese, G, Tannir, NM, Wood, CG, Karam, JA, Msaouel, P. Combining Neddylation Inhibition with Chemotherapy to Treat Renal Medullary Carcinoma, 2021.
18. Smith, S, Rao, P. Urothelial Dysplasia:, 2020.
19. Oramas, D, Rao, P, Tamboli, P, Sircar, K. Response to Immune Checkpoint Therapy and Clinical Outcome is not related to proportion of Sarcomatous Component in Sarcomatoid Renal Cell Carcinoma, 2020.
20. Wilson, N, Rao, P. Efficacy of Gemcitabine plus Doxorubicin (Gem + Dox) in Patients with Renal Medullary Carcinoma (RMCC), 2020.
21. Hamza, A, Rao, P. The case for subspecialized care in the diagnosis and handling of penile carcinoma, 2020.
22. Oramas D, Rao P, Tamboli P, Sircar K. Response to Immune Checkpoint Therapy and Clinical Outcome is Not Related to Proportion of Sarcomatous Component in Sarcomatoid Renal Cell Carcinoma. United States and Canadian Academy of Pathology, 2020. e-Pub 2020.
23. Hamza, A, Rao, P. The case for subspecialized care in the diagnosis and handling of penile carcinoma. CAP Meeting, 2020. e-Pub 2020.
24. Chadoud, J, Rao, P. Penile Squamous Cell Carcinoma is Genomically similar to other HPV-driven tumors, 2019.
25. Chadoud J, Rao P. Penile squamous cell carcinoma is genomically similar to other HPV-driven tumors. Genitourinary Cancers Symposium, 2019. e-Pub 2019.
26. Akgul M, Rao P, Tamboli P, Sircar K. TP53 and PTEN Mutational Status and Outcome Prediction in Chromophobe Renal Cell Carcinoma. United States and Canadian Academy of Pathology, 2019. e-Pub 2019.
27. Fine, SW, Rao, P. Practice Patterns in Reporting Teritary Grades at Radical Prostatectomy, 2019.
28. Hwang, M, Rao, P. Staging Post-Immunotherapy Renal Cell Carcinoma, 2019.
29. Akgul, M, Rao, P, Tamboli, P. TP53 and PTEN Mutational Status and Outcome Prediction in Chromophobe Renal Cell Carcinoma, 2019.
30. Hwang, M, Rao, P. Staging Post-Immunotherapy Renal Cell Carcinoma – Do conventional specimen Handling and AJCC Staging guidelines apply?. United States and Canadian Academy of Pathology, 2019. e-Pub 2019.
31. Heitzman, J, Rao, P. Primary Paratesticular Rhabdomyosarcoma: A Clinicopathologic Study of 25 Cases, 2018.
32. Ma, S, Alouch, N, Rao, P, Sircar, K. Aggressive Chromophobe RCC (ChRCC) Are Molecularly and Immunochemically Separable From Indolent ChRCC, 2018.
33. Atherton, D, Rao, P. Renal Oncolytic Tumors with Hybrid Features Occurring in a Sporadic Setting: A Clinicopathologic Study of 22 Cases, 2018.
34. Ma S, Alouch N, Rao P Sircar K. Aggressive Chromophobe RCC (ChRCC) Are Molecularly and Immunochemically Separable From Indolent ChRCC, 2018. e-Pub 2018.
35. Liang L, Rao P. Urothelial Carcinoma with Loss of MSH2 and/or MSH6 Expression: A Clinicopathologic Study of 11 Cases. United States and Canadian Academy of Pathology, 2017. e-Pub 2017.
36. Samdani R, Rao P. Pathologic Features of Renal Carcinoma Following Anti-PD1 Therapy. A Clinicopathologic Analysis of 12 Cases. United States and Canadian Academy of Pathology, 2017. e-Pub 2017.
37. Shah HU, Sannananja B, Vikram R, Rao P, Prasad SR, Menias CO, Katabathina VS. All in the Family: Current Update on Genetics and Imaging of Hereditary Renal Cell Carcinomas. United States and Canadian Academy of Pathology, 2017. e-Pub 2017.
38. Gupta S, Johnson SH, Vasmatzis G, Rao P, Costello B, Leibovich BC, Thompson RH, Cheville JC, Sukov WR. 6p21 Amplified Renal Cell Carcinoma: A Distinct Entity with Potential Implications for Clinical Management. United States and Canadian Academy of Pathology, 2017. e-Pub 2017.
39. Ruiz-Cordero R, Rao P, Tamboli P, Singh R, Routbort MJ, Sircar K. Characterization of Driver Mutations in Hybrid Renal Oncocytic Tumors. United States and Canadian Academy of Pathology, 2017. e-Pub 2017.
40. Gill A, et al RP. Expanding the Clinicopathological Spectrum of Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: 42 Novel Tumors in 38 Patients. United States and Canadian Academy of Pathology, 2017. e-Pub 2017.
41. Hruska C, Rao P. Primary Neuroendocrine Tumors of the Kidney: A clinicopathologic analysis of 17 cases. Does the grading system matter. United States and Canadian Academy of Pathology, 2017. e-Pub 2017.
42. Rao P, et al DJ. Prognostic and pathologic factors determining outcome in pT2/pT3 penile carcinoma: Time for a revised staging system. United States and Canadian Academy of Pathology, 2016. e-Pub 2016.
43. Rao P, Naovarat B, Guo C, k S, Zhang M, Khalil F, Tamboli P, Pettaway CA, Spiess PE, Dhillon J. Inter-observer variability between experienced urologic pathologists in the grading of penile carcinoma. United States and Canadian Academy of Pathology, 2016. e-Pub 2016.
44. Rao P, Tamboli P, Pagliaro LC, Pettaway CA. Pathologic Prognostic Variables Determining Disease Specific Outcome In Patients With Metastatic Penile Carcinoma To The Lymph Nodes. A Single Institution Study Of 54 Patients. United States and Candadian Academy of Pathology, 2016. e-Pub 2016.
45. Divatia MK, Smith SC, Kunju LP, Hirsch M, Colecchia M, Hes O, Epstein JI, McKenney J, Salles PJ, Rao P, daCunha IW, Comperat E, Zampini C, de-P VM, Mehra R, Tomlins S, Amin MB. Renal Cell Carcinoma, Unclassified – Medullary Phenotype (RCCU-MP): Findings Supporting a Close Relationship with Renal Medullary Carcinoma (RMC). United States and Canadian Academy of Pathology, 2015. e-Pub 2015.
46. Divatia MK, Smith SC, Hes O, Epstein JI, McKenney J, Salles PG, Rao P, Kunju LP, daCunha IW, Colecchia M, Hirsch M, Comperat E, Zampini C, de-P VM, Amin MB, Zhang PL, Mehra R, Tomlins S, Amin MB. Refining the Diagnostic Criteria and Immunophenotype of Collecting Duct Carcinoma (CDC) in Light of Emerging Entities. United States and Canadian Academy of Pathology, 2015. e-Pub 2015.
47. Dhillon J, Tamboli P, Rao P. Renal Cell Carcinoma In Patients Under 30 Years Of Age- Clinical Characteristics and Morphologic Features Of 80 Cases. United States and Canadian Academy of Pathology, 2015. e-Pub 2015.
48. Goodman SM, Tamboli P, Rodriguez-Canales J, Parra E, Karam JA, Wood CG, Rao P. PD-L1 Expression by Immunohistochemistry in Clear Cell Renal Cell Carcinoma is Associated with High Tumor Stage and Nuclear Grade. United States and Canadian Academy of Pathology, 2015. e-Pub 2015.
49. Rao P, Fox PS, Tamboli P, Pagliaro LC, Pettaway CA. Prognostic Variables Determine Diseases Specific Outcome in Lymph Node Positive Penile Cancer: A Single Institution Study of 54 Patients. United States and Canadian Academy of Pathology, 2014. e-Pub 2014.
50. Atherton D, Sircar K, Tamboli P, Rao P. Renal Oncocytic Tumors with Hybrid features occurring in a Aporadic setting: A clinicopathologic study of 22 cases. United States and Canadian Academy of Pathology, 2013. e-Pub 2013.
51. Heitzman J, Rao P. Paratesticular Rhabdomyosarcoma: A Clinicopathologic Study of 25 Cases. United States and Canadian Academy of Pathology, 2013. e-Pub 2013.
52. Jj G, Sun J, He Q, War J, Rao P, Troncoso P, Araujo J, Ng Tang D, Chen H, Thall P, Wen S, Sharma P. Combination Therapy with Anti-CTLA-4 plus Leuprolide Acetate in the Pre-Surgical Setting of Patients with Regional, High-Risk Prostate Cancer. American Association for Cancer Research, 2012. e-Pub 2012.
53. P R, Monzon FA, Jonasch E, Tamboli P. Renal Tumors in Patients with Von Hippel-Lindau Disease- A Single Institutional Study Over 15 Years. United States and Canadian Academy of Pathology, 2012. e-Pub 2012.
54. Rao P Monzon FA, Jonasch E, Czerniak B, Tamboli P. Clear cell papillary renal cell carcinoma in Von Hippel-Lindau disease- A report of three cases of a unique in a distinct clinical setting. United States and Canadian Academy of Pathology, 2012. e-Pub 2012.
55. Rao P, Czerniak BA, Guo CC. Clear cell adenocarcinoma of the urethra. A clinicopathologic study of 16 cases, 2012. e-Pub 2012.
56. Tannir NM, Lim ZD, Rao P, Tamboli P, Atkinson B, Vaishampayan U, Plimack E, Rathmel K, Jonasch E. Outcome of Patients with Renal Medullary Carcinoma (RMC) Treated in the Era of Targeted Therapies (TT): A Multicenter Experience. American Society of Clinical Onoclogy Meeting, 2011. e-Pub 2011.
57. Rao P, Tamboli P. Immunohistochemical Expression of OCT 3/4 in Renal Medullary Carcinoma-A Potential Diagnostic Pitfall. United States and Canadian Academy of Pathology, 2011. e-Pub 2011.
58. Gulmann C, Paner GP, Parakh RS, Hansel DE, Shen SS, Ro JY, Annaiah C, Lopez-Beltra A, Rao P, Arara K, Cho YM, Alsabeh R, Amin MB. Immunohistochemical (IHC) Profile to Distinguish Urothelial from Squamous Differentiation in Carcinoma of Urothelial Tract. United States and Canadian Academy of Pathology, 2011. e-Pub 2011.
59. Annaiah C, Paner GP, Gulman C, Rao P, Ro JY, Hansel DE, Shen SS, Lopez-Beltran A, Arora K, Parakh RS, Herrera LP, Luthringer DJ, Zhai J, Cho JM, Amin MB. Detailed Immunohistochemical (IHC) Evaluation of Novel Markers Associated with Urothelial Differentiation in a Comprehensive Spectrum of Variants of Urothelial Carcinoma (UCa): A Study of 80 Cases. United States and Canadian Academy of Pathology, 2011. e-Pub 2011.
60. Herrera LP, Hes O, Hirsch M, Comperat E, Camparo P, Rao P, Picken M, Montironi R, Annaiah C, Arara K, Tamboli P, Westfall DE, Monzon FA, Amin MB. Clear Cell-Papillary Renal Cell Carcinoma (CP-RCC) Not Associated with End Stage Renal Disease: Clinicopathologic Analysis of 50 Tumors Confirming a Novel Subtype of Renal Cell Carcinoma (RCC) Occurring in a Sporadic Setting. United States and Canadian Academy of Pathology, 2011. e-Pub 2011.
61. Behdad A, Monzon FA, Hes O, Hirsch M, Michal M, Comperat E, Camparo P, Rao P, Picken M, Montironi R, Annaiah C, Herrera LP, Arora K, Westfall DE, Taboli P, Amin MB. Relationship Between Sporadic Clear Cell-Papillary Renal Cell Carcinoma (CP-RCC) and Renal Angiomyoadenomatous Tumor (RAT) of the Kidney: Analysis by Virtual-Karyotyping, Fluorescent in Situ Analysis and Immunohistochemistry (IHC). United States and Canadian Academy of Pathology, 2011. e-Pub 2011.
62. Rao P, Ayala AG, Meis JM. Parachordoma Involving Soft Tissue and Bone: A distinctive subgroup of myoepithelioma or Extra-Axial Chordoma?. United States and Canadian Academy of Pathology, 2010. e-Pub 2010.
63. Rao P, Meis JM. Primary Ewing Sarcoma (ES) Primitive Neuroectodermal (PNET) of the Kidney in Adults-Is Molecular Confirmation Necessary for Treatment?. United States and Canadian Academy of Pathology, 2010. e-Pub 2010.
64. Rao, P, Lopez-Terrada, D, Powers, MP, Prieto, VG. Atypical Lipomatous Tumor with Myxoid Change, 2010.
65. Rao P, Fuller GN, Prieto VG. Expression of Sox-9 in Metastatic Melanoma-a Potential Diagnostic Pitfall. American Society of Dermatopathology Meeting, 2009. e-Pub 2009.
66. Malhotra R, Zhang PL, Bonventre JV, Gupta R, Amin MB, Rao P, Amin M. Kidney Injury Molecular-1 (KIM-1) Expression in Sarcomatoid Differentiation in Renal Cell Carcinoma (RCC): Implications for Differential Diagnosis of Malignant Spindle Cell Lesions of the Kidney. United States and Canadian Academy of Pathology, 2009. e-Pub 2009.
67. Sher K, Rao P, Chen G, Guoit MC, Fahmy MA, Tanguay K, Aldape K, Sircar K. Oncofetal (IMP3) and Stem Cell Markers in Primary and Metastatic Renal Cell Carcinoma. United States and Canadian Academy of Pathology, 2009. e-Pub 2009.
68. Balzer B, Gupta R, Rao P, Paner GP, Amin M, McKenney JK, Lazar AJ, Amin MB. Dedifferentiated Liposarcoma (De-Diff LPS) Presenting as a Primary Renal Mass Resulting in a Nephrectomy: A Report of 8 Cases with Discussion of Differential Diagnostic Implications. United States and Canadian Academy of Pathology, 2009. e-Pub 2009.
69. Brown JG, Amin MB, Rao P, Lazar AJ, Paner GP, Gupta R, Cheville JC, Folpe. Primary Vascular Tumors of the Kidney: A Clinicopathologic Analysis of 26 Cases. United States and Canadian Academy of Pathology, 2009. e-Pub 2009.
70. Balzer B, Gupta R, Lazar AJ, Rao P, Amin MB. Pseudoliposarcomatous Changes in the Perinephric Adipose Tissue of Nephrectomy Specimens Mimicking Well Differentiated Retroperitoneal Liposarcoma: Evaluation in 200 Nephrectomies. United States and Canadian Academy of Pathology, 2009. e-Pub 2009.
71. Miick S, Fors Z, James AL, Wixon C, Nigwekar P, Kwon GY, Tadros YE, Gupta R, Parton AN, Reynolds M, Rittenbouse H Robin HS, Amin MB, Groskopf J. Detection of mRNA Fusion Transcripts of TMPRSS2:ETS family Chromosomal Rearrangements in Radical Prostatectomy Tissue from 100 Cases. United States and Canadian Academy of Pathology, 2009. e-Pub 2009.
72. Rao P, Lahat G, Dukah A, Halevi H, Xiao L, Changye Z, Smith DK, Pollock RE, d L, Lazar AJF. Angiosarcoma: Clinical, Pathological, and Molecular Predictors of Disease Specific Survival in 222 patients. United States and Canadian Academy of pathology, 2009. e-Pub 2009.
73. Sher K, Rao P, Chen G, Guoit MC, Fahmy MA, Tanguay K, Aldape K, Sircar K. Oncofetal (IMP3) and Stem Cell Markers in Primary and Metastatic Renal Cell Carcinoma. United States and Canadian Academy of Pathology, 2009. e-Pub 2009.
74. Rao P, Tamboli P, Tanguay S, Aldape KD, Sircar K. YKL-40 as a Marker of Epithelial to Mesenchymal Transition in Primary and Metastatic Renal cell Carcinoma. United States and Canadian Academy of Pathology, 2009. e-Pub 2009.
75. Miick S, Wixom C, Nigwekar P, Kwon G, Rittenhouse HS, Robin HS, Amin MB, Groskopf J, Fors Z. Detection Of mRNA Fusion Transcripts Of TMPRSS2:Etsfamily Chromosomal Rearrangements In Prostate Cancer Measured In Radical Prostatecotmy Tissue From 100 Cases. The Genitourinary Cancers Symposium, 2008. e-Pub 2008.
76. Rao P, Miick S, Wixom C, Rittenhouse H, Groskopf J, G-Y K, Tadros Y, Gupta R, Robin H, Amin MB. Morphologic Correlates of Individual Splice Variants of TMPRSS2-ETS Prostate Cancer Detected by Transcription Mediated Amplification in Radical Prostatectomy Specimens. United Sates and Canadian Academy of Pathology, 2008. e-Pub 2008.

Book Chapters

1. Agaimy A, Oda Y, Comperat EM, Hatrmann A, Colombo P, Montironi R, Rao P, Sirohi D. SMARB1 deficient renal medullary carcinoma WHO Classification of Tumors. In: In: Urinary and Male Genital Tumors 5th edition. World Health Organization, 2022.
2. Gill AJ, Jimenez RE, Rao P, Tpkov K. Succinate dehydrogenase deficient renal cell carcinoma WHO Classification of tumors. In: In: Urinary and Male Genital Tumous 5th edition. World Health Organization, 2022.
3. Rao, P, Hippel-Lindau V. Syndrome WHO Classification of Tumors. In: In: Urinary and Male Genital Tumors 5th edition. World Health Organization, 2022.
4. Rao, P, Tamboli, P. Pathology Renal Cell Carcinoma. In: In: In Renal Cell Carcinoma. Oxford American Oncology Library Chapter 2, 2021.
5. Rao, P, Perrino, CM, Zynger, DL, Jorda, M, Tamboli, P, Sanchez, DF, Cubilla, AL, Iczkowski, KA, Zhang, M, Sircar, K. Genitourinary pathology (including adrenal gland). In: Oncological Surgical Pathology. Publisher Springer International Publishing, 1523-1726, 2020.
6. Msaouel, P, Rao, P, Tannir, NM. Renal medullary carcinoma. In: In Rare Kidney Tumors: Comprehensive Multidisciplinary Management and Emerging Therapies. Springer International Publishing, 65-75, 2018.
7. Rao, P, Tamboli, P. Pathology of Penile Cancer and Its Precursor Lesions. In: Penile Cancer Diagnosis of Treatment. Humana Press, 43-63, 2013.

Books (edited and written)

1. Rao, P, Sircar K. Oncologic Surgical Pathology. In: Urologic Pathology, 2020.

Letters to the Editor

1. Rao, P, Tamboli, P. Do clear cell papillary renal cell carcinomas occur in patients with von Hippel-Lindau disease? - Reply. Human Pathology 46: 341-343, 2015.